Total raised
$65.0M
Last: Series A 2025-05
Stage
Series A
Founded
2023
Headcount
45
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
PhaseV develops a platform for adaptive clinical trial design and closed-loop execution, leveraging an intuitive user interface and flexible software architecture along with cutting-edge algorithms such as reinforcement learning and causal ML to support key clinical decisions at any point during the trial.
Funding history · 2 rounds · $65.0M total
2025-05
Series A
$50.0M
2023-01
Seed
$15.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareClinical Workflow
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareLaboratories
Business model
B2B
Highlights
Verified
Tags
data-science-platformclinical-trialslife-sciencesmachine-learning